SCHEMBL7346348

SCHEMBL7346348

N=C(N)c1ccc2cc(-c3cccc(C=O)c3)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLAU P00749 10/20 0.56
TRIM24 O15164 1/20 0.55
TRIM33 Q9UPN9 1/20 0.55
PLG P00747 5/20 0.52
KLK1 P06870 4/20 0.52
PLAT P00750 3/20 0.52
PRSS1 P07477 5/20 0.51
F2 P00734 4/20 0.51
KLKB1 P03952 2/20 0.51
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
F12 P00748 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
F10 P00742 1/20 0.43
ASIC3 Q9UHC3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4687383 0.88 TRIM24 (0.66) PLAUTRIM24TRIM33PRSS1F2
SCHEMBL7342926 0.79 PLAU (0.74) PLAUPLGKLK1PLATPRSS1
SCHEMBL7433812 0.79 UNG (0.60) PLGPRSS1F2F12PRSS2
SCHEMBL10227496 0.77 TRIM24 (0.54) TRIM24TRIM33CA12CA1CA2
Hydrochloric Acid SCHEMBL6816751 0.77 UNG (0.58) PLGPRSS1F2PRSS2PRSS3
SCHEMBL12607522 0.76 TRIM24 (0.73) TRIM24TRIM33CA12CA1CA2
SCHEMBL11770226 0.73 TRIM24 (0.71) TRIM24TRIM33CA12CA1CA2
SCHEMBL346974 0.73 TRIM24 (0.64) TRIM24TRIM33CA12CA1CA2
SCHEMBL7333988 0.73 PLAU (1.00) PLAUPLGKLK1PLATPRSS1
Trifluoroacetic Acid SCHEMBL7345645 0.72 PLAU (0.59) PLAUPLGKLK1PLATPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 US disclosed
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 US disclosed
US-6258822-B1 ENZYME INHIBITORS OF NAPHTHALENE AMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-07-10 US disclosed
EP-1000018-A2 UROKINASE INHIBITORS Abbott Laboratories (US) 2000-05-17 EP disclosed
WO-1999005096-A2 UROKINASE INHIBITORS ABBOTT LABORATORIES (US) 1999-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049374-A1 Urokinase inhibitors SERPINE1, PLAU, SERPINB1 PLAU 2/4885TRIM24 3680/4885TRIM33 4726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.